Listado de ensayos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: New visual processing unit (VPU) with asymmetric waveforms Device: New VPU with bipolar stimulation

Localizaciones

University of Michigan, Ann Arbor, Michigan, United States

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: Argus II Eyeglasses Device: ORCAM

Localizaciones

Mayo Clinic in Rochester, Rochester, Minnesota, United States

Patología

RETINOSIS PIGMENTARIA

Localizaciones

Department of Ophthalmology Retinal Degenerations Clinic, UCSF, San Francisco, California, United States

Patología

RETINOSIS PIGMENTARIA Eye Diseases

Localizaciones

Associated Retina Consultants, Phoenix, Arizona, United States Stanford Department of Ophthalmology, Palo Alto, California, United States University of California-San Diego: Shirley Eye Institute, San Diego, California, United States University of California, San Francisco, San Francisco, California, United States Colorado Retina Associates, Denver, Colorado, United States National Eye Institute (NEI), Washington, District of Columbia, United States Vitreo-Retinal Associates, Gainesville, Florida, United States University of Miami: Neuro-ophthalmology Department, Miami, Florida, United States Emory Eye Center, Atlanta, Georgia, United States University of Kentucky, Lexington, Kentucky, United States and 17 more

Patología

Pigmentary Retinopathy

Tratamiento

Behavioral: Locomotion task Behavioral: Posturology task SOT (Sensory Organization Test) Behavioral: The quality of life questionnaire

Localizaciones

Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Biological: CNS10-NPC implantation

Localizaciones

Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States

Patología

RETINOSIS PIGMENTARIA Associated With CNGB1 Mutations

Tratamiento

Other: No intervention, this is a natural history progression study

Localizaciones

Dr. Stephen H. Tsang, New York, New York, United States Wills Eye Hospital, Philadelphia, Pennsylvania, United States Institut de la Vision/Centre de maladies rares du Centre Hospitalier National Ophtalmologique des Quinze-Vingts, Paris, France Klinikum der Universit t M nchen University Eye Hospital, Ludwig-Maximilians-University (LMU) Munich, M nchen, Bavaria, Germany Eberhard Karls University Tubingen, Tuebingen, Germany Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom

Patología

X-Linked RETINOSIS PIGMENTARIA

Tratamiento

Biological: 4D-125 IVT Injection Other: Observational

Localizaciones

University of Colorado, Aurora, Colorado, United States University of Michigan Kellogg Eye Center, Ann Arbor, Michigan, United States Duke University Eye Center/Dept. of Ophthalmology, Durham, North Carolina, United States Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States Retina Foundation of the Southwest, Dallas, Texas, United States University of Utah John A. Moran Eye Center, Salt Lake City, Utah, United States

Patología

X-Linked RETINOSIS PIGMENTARIA

Tratamiento

Biological: Genetic: AAV5-RPGR

Localizaciones

Vitreol Retinal Associates, Gainesville, Florida, United States The Emory Eye Centre, Atlanta, Georgia, United States Massachusetts Eye and Ear, Centre for Clinical Research Operations, Boston, Massachusetts, United States University of Michigan, Ann Arbor, Michigan, United States Retinal Consultants of Houston, Bellaire, Texas, United States

Patología

X-Linked RETINOSIS PIGMENTARIA

Tratamiento

Biological: Genetic: AAV5-RPGR 4e11 Biological: Genetic: AAV5-RPGR 2e11

Localizaciones

Vitreo Retinal Associates, Gainesville, Florida, United States The Emory Eye Centre, Atlanta, Georgia, United States Boston Eye and Ear, Boston, Massachusetts, United States Univeristy of Michigan, Ann Arbor, Michigan, United States Retinal Consultants of Houston, Bellaire, Texas, United States